Journal article
Human papillomavirus infections and vulvar disease development
SM Garland, RP Insinga, HL Sings, RM Haupt, EA Joura
Cancer Epidemiology Biomarkers and Prevention | Published : 2009
Abstract
Background: We describe the prevalence of 14 common types [human papillomavirus (HPV)-6/11/16/18/ 31/33/35/39/45/51/52/56/58/59] in vulvar intraepithelial neoplasia grades 1 to 3 (VIN 1-3) and HPV genotype-specific infection in relation to the development of VIN 1-3. Methods: Data were analyzed from women enrolled in the placebo arms of three randomized double-blind trials. Anogenital examinations, including collection of labial/vulvar/perineal/ perianal swabs, occurred at day 1 and every 6 to 12 months through 48 months. Lesions that were possibly, probably, or definitely HPV related or of unknown etiology were biopsied. Biopsies and swabs were HPV typed. Biopsies were read for endpoint det..
View full abstractGrants
Funding Acknowledgements
Merck Research Laboratories; grant support from Commonwealth Serum Laboratories, and, through her institution, Merck and GlixoSmithKline (to do clinical trials for human papillomavirus/cervical cancer vaccines; S.M. Garland); and funding through the Medical University of Vienna (E.A. Joura)